Femasys stock.
The Femasys Inc. stock price fell by -3.27% on the last day (Wednesday, 29th Nov 2023) from $1.01 to $0.98. During the last trading day the stock fluctuated 6.91% from a day low at $0.96 to a day high of $1.03. The price has fallen in 5 of the last 10 days but is still up by 5.05% over the past 2 weeks.
The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. In depth view into FEMY (Femasys) stock including the latest price, news, dividend history, earnings information and financials.FemBloc® patent application provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth controlATLANTA, July 27, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ ...Femasys Inc. (NASDAQ: FEMY) shares fell lower on Wednesday, a pullback from Tuesday's surge in price following the announcement that the company received FDA 510(k) clearance for FemaSeed, Femasys Stock Earnings. The value each FEMY share was expected to gain vs. the value that each FEMY share actually gained. Femasys ( FEMY) reported Q3 2023 earnings per share (EPS) of -$0.26, missing estimates of -$0.22 by 21.75%. In the same quarter last year, Femasys 's earnings per share (EPS) was -$0.25. Femasys is expected to release next ...
ATLANTA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...Jul 27, 2023 · Shares of biomedical firm Femasys soared on Thursday.; Management announced the issuance of a notice of allowance for its patent application. FEMY stock soared on IP protection of its first-of-its ...
ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide …WebATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...
RTTNews. Nov. 15, 2023, 08:41 AM. (RTTNews) - PharmaCyte Biotech, Inc. (PMCB) has made a $5 million investment in Femasys, Inc. (FEMY), a biomedical company. Femasys offers a broad portfolio of in ...Dec 1, 2023 · Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. The stock of Femasys Inc (FEMY) has seen a -20.00% decrease in the past week, with a -27.78% drop in the past month, and a 152.43% flourish in the past quarter. The volatility ratio for the week is 12.52%, and the volatility levels for the past 30 days are at 13.78% for FEMY. The simple […]The latest price target for . Femasys (NASDAQ: FEMY) was reported by HC Wainwright & Co. on November 14, 2023.The analyst firm set a price target for $10.00 expecting FEMY to rise to within 12 ... Femasys Inc stock performance at a glance. Check Femasys Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.
The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...
Femasys has an analyst consensus of Strong Buy, with a price target consensus of $7.33, representing a 543.0% upside. In a report issued on September 26, JonesTrading also maintained a Buy rating ...
FEMASYS INC. EMPLOYEE STOCK PURCHASE PLAN 1. SECTION 1. PURPOSE OF THE PLAN. The Femasys Inc. Employee Stock Purchase Plan (the “Plan”) is intended to provide Eligible Employees (as defined below) the opportunity to increase their proprietary interest in Femasys Inc. (the “Company”) by conveniently purchasing shares of the …When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the ...At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Nov 29, 2023 · Femasys GAAP EPS of -$0.22 misses by $0.02, revenue of $0.32M misses by $0.05M SA News Thu, Aug. 10 Femsys stock jumps 21% after FDA green lights FemBloc testing ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...FEMY Femasys Bull Pennant On 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target How do you explain such a big difference in valuation?
Sep 27, 2023 · Femasys has a market capitalisation of US$22m and burnt through US$11m last year, which is 50% of the company's market value. ... It does not constitute a recommendation to buy or sell any stock ... Femasys Inc. (FEMY) delivered earnings and revenue surprises of -8.70% and 13.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?FEMY - Femasys Inc Stock Price and Quote Nov-23-23 03:38PM 20 Countries with the Highest Teenage Pregnancy Rates (Insider Monkey) Nov-15-23 08:30AM PharmaCyte …WebUnder the terms of the investment, the investors were also issued two series of warrants: warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per share expiring one year from issuance and warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.475 per …Femasys GAAP EPS of -$0.22 misses by $0.02, revenue of $0.32M misses by $0.05M SA News Thu, Aug. 10 Femsys stock jumps 21% after FDA green lights FemBloc testingDec 2, 2023 · Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved by -33.09% in ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Femasys Inc. (FEMY) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. 1.0300 +0.1162 (+12.72%) At close: …
SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 11/30/2023. S-3. Securities Registration Statement (simplified form) 11/29/2023. 8-K. Current report filing.
NASDAQ:FEMY - Femasys Stock Price, News & Analysis Femasys Stock Price, News & Analysis (NASDAQ:FEMY) $0.98 -0.03 (-2.98%) (As of 11/29/2023 ET) …WebOverview. Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health.Employees: 30. 3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, GA 30024. 770-500-3910. femasys.com. Femasys Inc. focuses on women's healthcare market in the United States. The company develops permanent birth …Get Femasys Inc (FEMY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsShares Outstanding 21.65 M Public Float 19.48 M Yield FEMY is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) …WebAt Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Femasys, a medical device company, ... Its stock ran from $0.33 to an intraday high of $4.75 a few days later, only to fall back to the $1 range. During that flurry of activity, ...
On June 22, 2021, Femasys Inc. (the “Company”) filed an eleventh amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the completion of the Company’s initial public offering of its common stock (the “IPO”).
Femasys ( NASDAQ: FEMY) shares jumped 21% midday Monday following news that the US Food and Drug Administration has approved its investigational device exemption application to begin clinical ...
Get the latest Femasys Inc (FEMY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Description. Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient ... Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our ...Femasys Inc. FEMYNASDAQ FEMYNASDAQ 0.9138USD +0.0118 +1.31% At close at 16:59 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …WebSep 25, 2023 · Femasys’ FemBloc ® permanent birth control in late-stage clinical development is the first and only non-surgical, in-office, permanent birth control method intended to be a safer option for ... Femasys Inc (NASDAQ:FEMY) trade information. Femasys Inc (FEMY) registered a -2.33% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.33% in intraday trading to $0.93 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -9.71%, and it has moved …Femasys was previously notified by Nasdaq on June 1, 2023 that it was not in compliance with the minimum bid price rule (“the Rule”) because its common stock failed to meet the closing bid ...(RTTNews) - Femasys Inc. (FEMY) announced on Monday that the FDA has granted 510(k) Clearance for FemaSeed, an option for intratubal artificial insemination that enhances the natural fertilization ...ATLANTA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office ...SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 11/30/2023. S-3. Securities Registration Statement (simplified form) 11/29/2023. 8-K. Current report filing.
Fundamentals Market Capitalization, $K 14,544 Shares Outstanding, K 15,073 Annual Sales, $ 1,210 K Annual Income, $ -11,390 K 60-Month Beta -3.56 Price/Sales 11.50 …WebInstitutional Ownership and Shareholders. Femasys Inc (US:FEMY) has 32 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,650,299 shares. Largest shareholders include Clear Street Llc, Clear Creek Financial Management, LLC, Bank Of America ...Get the latest Femasys Inc. (FEMY) stock news and headlines to help you in your trading and investing decisions.Femasys saw a decline in short interest in November. As of November 15th, there was short interest totaling 286,700 shares, a decline of 33.0% from the previous total of 427,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will ...Instagram:https://instagram. cost stock forecastcommunications bookfranco nevada stock pricehighest margin broker FEMY Earnings Date and Information. Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates. Read More.- The 510(k) Clearance from the United States Food and Drug Administration (FDA) allows for the U.S. commercialization of FemaSeed ®, an intratubal artificial insemination option designed to augment the natural fertilization process - - FemaSeed ® is an innovative infertility treatment designed to deliver sperm directly to where conception … how can i learn to day tradeenterprise product partners stock Femasys Inc. is a biomedical company focused on meeting women’s unmet needs worldwide by developing a broad portfolio of innovative product candidates and products that include minimally ...Our Vision. Femasys is working to provide next generation advancements to disrupt severely under-served areas in women’s health. Technological advancements in female reproductive health are long overdue, driving our focus in permanent birth control and front-end infertility. how to open a paper trading account with td ameritrade FEMY | Complete Femasys Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 30, 2023 · Read Full Company Summary for FEMY here. View Femasys Inc FEMY investment & stock information. Get the latest Femasys Inc FEMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What To Know: HC Wainwright & Co. analyst Emily Bodnar maintained Femasys with a Buy rating and raised the price target from $5 to $13 on Friday. Femasys also announced last week that it has ...